AlphaYouRVMD: Cislini Jeff discloses a sale
By AlphaYouPublished Form 4
Cislini Jeff
Reporting filer
Cislini Jeff reported Sale in Revolution Medicines, Inc.: 52 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 18, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cislini Jeff | 2026-09-16 | S | Sale | 52 | 195.0087 | 55,855 | 2 days | Filed terms
|
| Common Stock | Cislini Jeff | 2026-09-16 | S | Sale | 3314 | 199.3032 | 52,541 | 2 days | Filed terms
|
Common Stock
- Owner
- Cislini Jeff
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 52
- Price
- 195.0087
- Following holdings
- 55,855
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 52
- transaction Price Per Share: 195.0087
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 55855
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Cislini Jeff
- Date
- 2026-09-16
- Code
- S
- Action
- Sale
- Quantity
- 3314
- Price
- 199.3032
- Following holdings
- 52,541
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 3314
- transaction Price Per Share: 199.3032
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 52541
- id: F3
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cislini Jeff: SVP & General Counsel.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units.
- F2: The transaction was executed in multiple trades at prices ranging from $195.00 to $195.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3: Includes 37,088 restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.